DiscoverThe View on GU | with Lalani and WallisEpisode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025
Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

Update: 2025-04-30
Share

Description

With new bladder cancer therapies on the horizon, Dr. Lalani and Dr. Wallis review promising trial results - including EVER, CREST and the CISTO Study -presented at this year’s annual meeting. They also address key practical challenges for bladder cancer treatment, from both a medical oncologist and a urologic oncologist's perspective.


The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca

This podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, J&J, Merck, Pfizer, Eisai and AbbVie.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

Dr. Aly-Khan Lalani & Dr. Christopher Wallis